Engineering biomaterial-associated complement activation to improve vaccine efficacy

Biomacromolecules

Volumn 14, Issue 9, 2013, Pages 3321-3328

  Liu, Yuan ^a,b   Yin, Ying ^c   Wang, Lianyan ^a   Zhang, Weifeng ^a,b   Chen, Xiaoming ^a,b   Yang, Xiaoxiao ^a   Xu, Junjie ^c   Ma, Guanghui ^a  

^a INSTITUTE OF PROCESS ENGINEERING   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; COMPLEMENT ACTIVATIONS; COMPLEMENT SYSTEMS; DESIGN PRINCIPLES; PROLIFERATIVE RESPONSE; PROTECTIVE ANTIGENS; VACCINE ADJUVANTS; VACCINE EFFICACIES;

ANTIGENS; CHEMICAL ACTIVATION;

VACCINES;

ADJUVANT; ANTHRAX VACCINE; CHITOSAN; COMPLEMENT COMPONENT C3A; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFICACY; EX VIVO STUDY; FEMALE; FOLLICULAR DENDRITIC CELL; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; SPLEEN CELL; ZETA POTENTIAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTHRAX; ANTIBODY FORMATION; CELL PROLIFERATION; CELLS, CULTURED; CHITOSAN; COMPLEMENT ACTIVATION; CYTOKINES; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICROSPHERES; PARTICLE SIZE; SURFACE PROPERTIES; T-LYMPHOCYTES; VACCINE POTENCY;

EID: 84883763505     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm400930k     Document Type: Article

References (38)

1. Leleux, J.; Roy, K. Micro and Nanoparticle-Based Delivery Systems for Vaccine Immunotherapy: An Immunological and Materials Perspective Adv. Healthcare Mater. 2013, 2, 72-94
2. Coffman, R. L.; Sher, A.; Seder, R. A. Vaccine Adjuvants: Putting Innate Immunity to Work Immunity 2010, 33, 492-503
3. Singh, M.; O'Hagan, D. Advances in Vaccine Adjuvants Nat. Biotechnol. 1999, 17, 1075-81
4. Kazzaz, J.; Singh, M.; Ugozzoli, M.; Chesko, J.; Soenawan, E.; O'Hagan, D. T. Encapsulation of the Immune Potentiators MPL and RC529 in PLG Microparticles Enhances Their Potency J. Controlled Release 2006, 110, 566-573
5. Auten, M. W.; Huang, W. T.; Dai, G. X.; Ramsay, A. J. CD40 Ligand Enhances Immunogenicity of Vector-Based Vaccines in Immunocompetent and CD4+T Cell Deficient Individuals Vaccine 2012, 30, 2768-2777
6. Klinman, D. M.; Klaschik, S.; Sato, T.; Tross, D. CpG Oligonucleotides As Adjuvants for Vaccines Targeting Infectious Diseases Adv. Drug Delivery Rev. 2009, 61, 248-255
7. Kumar, M.; Behera, A. K.; Hu, J. N.; Lockey, R. F.; Mohapatra, S. S. IFN-Gamma and IL-12 Plasmid DNAs As Vaccine Adjuvant in a Murine Model of Grass Allergy J. Allergy Clin. Immunol. 2001, 108, 402-408
8. Reddy, S. T.; van der Vlies, A. J.; Simeoni, E.; Angeli, V.; Randolph, G. J.; O'Neill, C. P.; Lee, L. K.; Swartz, M. A.; Hubbell, J. A. Exploiting Lymphatic Transport and Complement Activation in Nanoparticle Vaccines Nat. Biotechnol. 2007, 25, 1159-1164
9. Thasneem, Y. M.; Sajeesh, S.; Sharma, C. P. Effect of Thiol Functionalization on the Hemo-Compatibility of PLGA Nanoparticles J. Biomed. Mater. Res. A 2011, 99A, 607-617
10. Mizrahy, S.; Raz, S. R.; Hasgaard, M.; Liu, H.; Soffer-Tsur, N.; Cohen, K.; Dvash, R.; Landsman-Milo, D.; Bremer, M. G. E. G.; Moghimi, S. M.; Peer, D. Hyaluronan-Coated Nanoparticles: The Influence of the Molecular Weight on CD44-Hyaluronan Interactions and on the Immune Response J. Controlled Release 2011, 156, 231-238
11. Merkel, O. M.; Urbanics, R.; Bedocs, P.; Rozsnyay, Z.; Rosivall, L.; Toth, M.; Kissel, T.; Szebeni, J. In Vitro and in Vivo Complement Activation and Related Anaphylactic Effects Associated with Polyethylenimine and Polyethylenimine-graft-Poly(Ethylene Glycol) Block Copolymers Biomaterials 2011, 32, 4936-4942
12. Heeger, P. S.; Kemper, C. Novel Roles of Complement in T Effector Cell Regulation Immunobiology 2012, 217, 216-224
13. Pekkarinen, P. T.; Vaali, K.; Junnikkala, S.; Rossi, L. H.; Tuovinen, H.; Meri, S.; Vaarala, O.; Arstila, T. P. A Functional Complement System Is Required for Normal T Helper Cell Differentiation Immunobiology 2011, 216, 737-743
14. Moghimi, S. M.; Andersen, A. J.; Ahmadvand, D.; Wibroe, P. P.; Andresen, T. L.; Hunter, A. C. Material Properties in Complement Activation Adv. Drug Delivery Rev. 2011, 63, 1000-1007
15. Toda, M.; Kitazawa, T.; Hirata, I.; Hirano, Y.; Iwata, H. Complement Activation on Surfaces Carrying Amino Groups Biomaterials 2008, 29, 407-417
16. Salvador-Morales, C.; Zhang, L. F.; Langer, R.; Farokhzad, O. C. Immunocompatibility Properties of Lipid-Polymer Hybrid Nanoparticles with Heterogeneous Surface Functional Groups Biomaterials 2009, 30, 2231-2240
17. Camacho, A. I.; Martins, R. D.; Tamayo, I.; de Souza, J.; Lasarte, J. J.; Mansilla, C.; Esparza, I.; Irache, J. M.; Gamazo, C. Poly(methyl vinyl ether-co-maleic anhydride) Nanoparticles As Innate Immune System Activators Vaccine 2011, 29, 7130-7135
18. Mao, S. R.; Sun, W.; Kissel, T. Chitosan-Based Formulations for Delivery of DNA and siRNA Adv. Drug Delivery Rev. 2010, 62, 12-27
19. Senel, S.; McClure, S. J. Potential Applications of Chitosan in Veterinary Medicine Adv. Drug Delivery Rev. 2004, 56, 1467-1480
20. Garcia-Fuentes, M.; Alonso, M. J. Chitosan-Based Drug Nanocarriers: Where Do We Stand? J. Controlled Release 2012, 161, 496-504
21. Croisier, F.; Jerome, C. Chitosan-Based Biomaterials for Tissue Engineering Eur. Polym. J. 2013, 49, 780-792
22. Zhang, Y. L.; Wei, W.; Lv, P. P.; Wang, L. Y.; Ma, G. H. Preparation and Evaluation of Alginate-Chitosan Microspheres for Oral Delivery of Insulin Eur. J. Pharm. Biopharm. 2011, 77, 11-19
23. Lv, P. P.; Wei, W.; Gong, F. L.; Zhang, Y. L.; Zhao, H. Y.; Lei, J. D.; Wang, L. Y.; Ma, G. H. Preparation of Uniformly Sized Chitosan Nanospheres by a Premix Membrane Emulsification Technique Ind. Eng. Chem. Res. 2009, 48, 8819-8828
24. Gadjeva, M.; Dodds, A. W.; Taniguchi-Sidle, A.; Willis, A. C.; Isenman, D. E.; Law, S. K. A. The Covalent Binding Reaction of Complement Component C3 J. Immunol. 1998, 161, 985-990
25. Ekdahl, K. N.; Lambris, J. D.; Elwing, H.; Ricklin, D.; Nilsson, P. H.; Teramura, Y.; Nicholls, I. A.; Nilsson, B. Innate Immunity Activation on Biomaterial Surfaces: A Mechanistic Model and Coping Strategies Adv. Drug Delivery Rev. 2011, 63, 1042-1050
26. Fischer, M.; Sperling, C.; Tengvall, P.; Werner, C. The Ability of Surface Characteristics of Materials to Trigger Leukocyte Tissue Factor Expression Biomaterials 2010, 31, 2498-2507
27. Sarma, J. V.; Ward, P. A. The Complement System Cell Tissue Res. 2011, 343, 227-235
28. Carroll, M. C. Complement and Humoral Immunity Vaccine 2008, 26, I28-I33
29. Villiers, M. B.; Villiers, C. L.; Laharie, A. M.; Marche, P. N. Amplification of the Antibody Response by C3b Complexed to Antigen through an Ester Link J. Immunol. 1999, 162, 3647-3652
30. Lyubchenko, T.; Dal Porto, J. M.; Holers, V. M.; Cambier, J. C. Cutting Edge: Complement (C3d)-Linked Antigens Break B cell Anergy J. Immunol. 2007, 179, 2695-2699
31. Kolla, R. V.; Chintalapati, S.; Sabet, M.; Santelli, E.; Liddington, R. C.; David, M.; Fierer, J.; Guiney, D.; Rickert, R. C. Complement C3d Conjugation to Anthrax Protective Antigen Promotes a Rapid, Sustained, and Protective Antibody Response. PLoS One 2007, 2.
32. Thomas, S. N.; van der Vlies, A. J.; O'Neil, C. P.; Reddy, S. T.; Yu, S. S.; Giorgio, T. D.; Swartz, M. A.; Hubbell, J. A. Engineering Complement Activation on Polypropylene Sulfide Vaccine Nanoparticles Biomaterials 2011, 32, 2194-2203
33. Masopust, D.; Schenkel, J. M. The Integration of T Cell Migration, Differentiation and Function Nat. Rev. Immunol. 2013, 13, 309-20
34. Dunkelberger, J. R.; Song, W. C. Role and Mechanism of Action of Complement in Regulating T cell Immunity Mol Immunol. 2010, 47, 2176-2186
35. Heeger, P. S.; Lalli, P. N.; Lin, F.; Valujskikh, A.; Liu, J. B.; Muqim, N.; Xu, Y. Y.; Medof, M. E. Decay-Accelerating Factor Modulates Induction of T Cell Immunity J. Exp. Med. 2005, 201, 1523-1530
36. Liu, J. N.; Miwa, T.; Hilliard, B.; Chen, Y. H.; Lambris, J. D.; Wells, A. D.; Song, W. C. The Complement Inhibitory Protein DAF (CD55) Suppresses T Cell Immunity in Vivo J. Exp. Med. 2005, 201, 567-577
37. Strainic, M. G.; Liu, J. B.; Huang, D. P.; An, F.; Lalli, P. N.; Muqim, N.; Shapiro, V. S.; Dubyak, G. R.; Heeger, P. S.; Medof, M. E. Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4(+) T Cells Immunity 2008, 28, 425-435
38. Kemper, C.; Atkinson, J. P. T-Cell Regulation: With Complements from Innate Immunity Nat. Rev. Immunol. 2007, 7, 9-18